U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06918587) titled 'Open Label Randomized Comparative Crossover Pharmacokinetic and Immunogenicity Study' on Jan. 31.
Brief Summary: The Goal of these study is to evaluate and To compare the pharmacokinetics (PK) of the Test product (T) getting administered through prefilled syringe with on-body injector with Reference product as prefilled syringe following a single 6 mg dose administered through subcutaneous route in healthy adult Human subjects.
Subjects safety and immunogenicity will also be evaluated during these study as follows Safety - monitoring the adverse events , vitals signs, ECG, laboratory parameters, and injection site assessment.
Imm...